Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates
Kp. Hunfeld et al., Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates, INT J ANT A, 15(1), 2000, pp. 11-17
The spectrum of antibiotic susceptibility of Borrelia burgdorferi has been
only partially defined. In the present study the effectiveness of 12 antimi
crobials, belonging to six different antibiotic classes have been tested ag
ainst Borrelia burgdorferi s.s. (N = 3), Borrelia garinii (N = 3), Borrelia
afzelii (N = 3), Borrelia valaisiana (N = 1), and Borrelia bissettii (N =
1) isolates. These isolates were analysed by a new standardised colorimetri
c minimal inhibitory concentration (MIC) method based upon colour changes t
hat result from actively metabolizing spirochaetes after 72 h of incubation
. Piperacillin (MIC90: 0.08 mg/l), ceftriaxone (MIC90: 0.04 mg/l), cefotaxi
me (MIC90: 0.15 mg/l), azithromycin (MIC90: 0.015 mg/l), roxithromycin (MIC
90: 0.05 mg/l) and quinupristin/dalfopristin (MIC90: 0.12 mg/l) gave the lo
west MIC values. Minimal inhibitory activity of amoxycillin (MIC90: 1.04 mg
/l), cefixime (MIC90: 1.33 mg/l), cefoperazone (MIC90: 0.83 mg/l) tetracycl
ine (MIC90: 0.29 mg/l) and minocycline (MIC90: 0.30 mg/l) was slightly lowe
r, whereas borrelia were resistant to amikacin (MIC90: >128 mg/l). Mean min
imal borreliacidal concentrations (MBCs) were representatively determined f
or piperacillin (MBC: 1.8 mg/l), ceftriaxone (MBC: 2.0 mg/l), azithromycin
(MBC: 0.82 mg/ml), roxithromycin (MBC: 1.8 mg/l), quinupristin/dalfopristin
(MBC: 5.0 mg/l), minocycline (MBC: 5.8 mg/l), and amikacin (MBC: >128 mg/l
) by using conventional subculture for three weeks in combination with dark
-field microscopy. B. garinii proved to be the most susceptible of the geno
species tested. Our study showed excellent in vitro antimicrobial activity
of all classes of antibiotics tested, except the aminoglycosides and hence
their suitability for therapy of Lyme disease. (C) 2000 Elsevier Science B.
V. and International Society of Chemotherapy. All rights reserved.